Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 7NIH 1FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Lung Neoplasms 1

Interventions

pembrolizumab 2apalutamide 2abiraterone 2Testosterone 2Radiosurgery 2Leuprolide 2Golytely 2Exercise 2Cryotherapy 2Abiraterone Acetate 2zanubrutinib 1venetoclax 1stenoparib 1relugolix 1olaparib 1nilutamide 1leucoselect phytosome 1ibrutinib 1histrelin 1enzalutamide 1copanlisib 1capivasertib 1bicalutamide 1avelumab 1acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1acalabrutinib 1Waiting Lists 1Triptorelin Pamoate 1Temozolomide 1Surveys and Questionnaires 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
FED × Waiting Lists × 1 year × Clear all
NCT05179408 2026-01-27

Targeted Telerehabilitation Following Curative Intent Therapy of Lung Cancer

VA Office of Research and Development

Phase NA Recruiting
40 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡